Portfolio (Quarterly)
Guide ↗
Rhenman & Partners Asset Management AB
· CIK 0001599882| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | BSX | BOSTON SCIENTIFIC CORP | Healthcare | 625,000.0 | $39.2M | 4.84% | +194K | +44.9% | $62.75 | -9.5% |
| 2 | INSM | INSMED INC | Healthcare | 159,760.0 | $26.1M | 3.22% | +46K | +40.6% | $163.52 | -35.3% |
| 3 | GILD | GILEAD SCIENCES INC | Healthcare | 167,750.0 | $23.4M | 2.88% | +42K | +33.0% | $139.37 | -7.6% |
| 4 | TMO | THERMO FISHER SCIENTIFIC INC | Healthcare | 41,340.0 | $20.3M | 2.51% | +8K | +22.9% | $491.53 | -9.8% |
| 5 | BIIB | BIOGEN INC | Healthcare | 109,100.0 | $20.0M | 2.47% | +17K | +18.1% | $183.33 | +3.4% |
| 6 | VRTX | VERTEX PHARMACEUTICALS INC | Healthcare | 43,485.0 | $19.4M | 2.40% | +9K | +26.9% | $446.54 | -2.7% |
| 7 | ALHC | ALIGNMENT HEALTHCARE INC | Healthcare | 1,053,450.0 | $18.6M | 2.29% | +44K | +4.4% | $17.62 | -6.9% |
| 8 | JAZZ | JAZZ PHARMACEUTICALS PLC | Healthcare | 75,890.0 | $14.3M | 1.77% | +2K | +2.5% | $189.05 | +23.5% |
| 9 | GH | GUARDANT HEALTH INC | Healthcare | 145,000.0 | $13.4M | 1.65% | +65K | +81.2% | $92.37 | +2.4% |
| 10 | MDGL | MADRIGAL PHARMACEUTICALS INC | Healthcare | 24,050.0 | $12.6M | 1.55% | +4K | +23.0% | $523.47 | -0.7% |
| 11 | RPRX | ROYALTY PHARMA PLC | Healthcare | 233,000.0 | $11.2M | 1.38% | +26K | +12.8% | $47.97 | +8.3% |
| 12 | NTRA | NATERA INC | Healthcare | 51,600.0 | $10.3M | 1.27% | +11K | +27.4% | $199.99 | -4.3% |
| 13 | ADPT | ADAPTIVE BIOTECHNOLOGIES COR | Healthcare | 720,000.0 | $10.0M | 1.23% | +115K | +19.0% | $13.88 | -9.1% |
| 14 | ELV | ELEVANCE HEALTH INC | Healthcare | 32,300.0 | $9.5M | 1.17% | +17K | +115.3% | $292.75 | +34.1% |
| 15 | — | IQVIA HLDGS INC | — | 53,000.0 | $9.0M | 1.11% | +26K | +100.0% | $170.54 | — |
| 16 | IDYA | IDEAYA Biosciences Inc | Healthcare | 255,500.0 | $8.5M | 1.05% | +6K | +2.2% | $33.32 | -13.7% |
| 17 | — | ANTERIS TECHNOLOGIES GLOBAL | — | 1,438,625.0 | $8.0M | 0.98% | +200K | +16.1% | $5.55 | — |
| 18 | OSCR | OSCAR HEALTH INC | Healthcare | 660,000.0 | $7.6M | 0.93% | +400K | +153.8% | $11.47 | +115.2% |
| 19 | IOVA | IOVANCE BIOTHERAPEUTICS INC | Healthcare | 2,055,327.0 | $7.2M | 0.89% | +460K | +28.8% | $3.51 | -5.3% |
| 20 | MLYS | MINERALYS THERAPEUTICS INC | Healthcare | 263,071.0 | $7.1M | 0.88% | +120K | +84.5% | $27.09 | -2.6% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
98.9%
Technology
1.1%